COMMUNIQUÉS West-GlobeNewswire

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

22/04/2024 - 18:00

COPENHAGEN, Denmark, April 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Anthos Therapeutics Announces Appointment of Bill Meury as CEO

22/04/2024 - 17:09

CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences (BXLS [...]

Nanox Files 2023 Annual Report on Form 20-F

22/04/2024 - 15:40

PETACH TIKVA, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report [...]

Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market

22/04/2024 - 15:27

Raised gross proceeds of $59 million through the issuance and sale of 5,000,000 of its ordinary shares to Icelandic institutional and existing investors Becomes second company dual-listed on NASDAQ U.S. and NASDAQ [...]

Ibogaine By David Dardashti Announces Female Neuroscientist To Offer Suggestions on Treating Women with Substance Abuse

22/04/2024 - 15:21

Misty Huckabey to Help Develop Treatment Algorithm for Women with Drug Addiction MIAMI, April 22, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti , a prominent drug addiction treatment center, is advancing their [...]

NH Community Health Worker (CHW) Summit Convenes on April 30

22/04/2024 - 15:13

Over 150 Attendees Focus on Increasing CHWs in Practices Littleton, NH, April 22, 2024 (GLOBE NEWSWIRE) -- Over 150 Community Health Workers (CHWs), healthcare providers, social workers, policymakers, and state agencies [...]

Novo Nordisk A/S - share repurchase programme

22/04/2024 - 15:06

Bagsværd, Denmark, 22 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Simple HealthKit Expands Access to At-Home Diagnostics and Follow-up Care for Diabetes, Respiratory Wellness and Sexual Wellness with Product Launch in Amazon’s U.S. Store

22/04/2024 - 15:00

Created by people who believe world-class care is a right, not a privilege, Simple HealthKit addresses high-need and high-impact health challenges in all communities FREMONT, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- [...]

Aeroflow Health Celebrates the Success of Nebraska’s Passage of Bill LB1215, Featuring Provisions to Include Access to Products & Services for Expecting and New Mothers

22/04/2024 - 15:00

The national durable medical equipment provider was active in achieving the necessary provisions in Bill L1215 to increase access to breast pumps and lactation consultations ASHEVILLE, N.C., April 22, 2024 (GLOBE [...]

VIVUS Announces it will Provide Telehealth to Patients through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth

22/04/2024 - 15:00

Collaboration will deliver a seamless telehealth experience, providing patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their healthcare journey CAMPBELL, Calif., April 22, 2024 ( [...]

APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023

22/04/2024 - 15:00

SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR ) (“ Mobile-Health ” or the “ Company ”), a pioneering Asia-Pacific (“APAC”) telehealth provider, today provided financial [...]

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

22/04/2024 - 15:00

BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to [...]

Cidara Therapeutics Announces Reverse Stock Split

22/04/2024 - 14:49

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) [...]

ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients

22/04/2024 - 14:45

Interim readout of 22 patients shows unprecedented efficacy data compared to prior atopic dermatitis (AD) studies with biologics: 60.0% of dupilumab -experienced AD patients treated with 400mg eblasakimab weekly [...]

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

22/04/2024 - 14:45

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]

Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market

22/04/2024 - 14:34

Raised gross proceeds of $59 million through the issuance and sale of 5,000,000 of its ordinary shares to Icelandic institutional and existing investors Becomes second company dual-listed on NASDAQ U.S. and NASDAQ [...]

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

22/04/2024 - 14:30

GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]

Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters

22/04/2024 - 14:30

Selective CVN293 may have treatment potential in multiple neurodegenerative conditions BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central [...]

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time

22/04/2024 - 14:30

SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]